Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» thrombotic microangiopathy
thrombotic microangiopathy
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
CP Wire
Tue, 10/23/18 - 11:00 pm
Omeros
OMS721
stem cells
thrombotic microangiopathy
FDA Grants Orphan Drug Designation to Omeros’ Treatment for Stem Cell Transplant-Associated Thrombotic Microangiopathy
Tue, 10/23/18 - 09:43 am
Omeros
OMS721
stem cell
thrombotic microangiopathy
Omeros Receives Orphan Designation in Europe for Treatment in Hematopoietic Stem Cell Transplantation
CP Wire
Wed, 08/29/18 - 10:26 am
Omeros
OMS721
thrombotic microangiopathy
Omeros Receives Orphan Designation in Europe for Treatment in Hematopoietic Stem Cell Transplantation
Tue, 08/28/18 - 11:53 am
Omeros
OMS721
thrombotic microangiopathy